In 2016, there were over 200,000 mHealth apps available, according to IMS Health. Yet of those, less than 300 have FDA clearance and only 50 are backed by clinical trials. There are even less in the diabetes space. Patients, payers and HCPs don’t know where to turn to find digital diabetes solutions that improve outcomes, enhance care quality and decrease costs. This presentation will look at the rapid increase in diabetes mobile apps, their pros and cons, and review innovations that work.